CD276 Recombinant Protein (OPCD01998) from Aviva Systems Biology

Supplier Page

Supplier Page from
Aviva Systems Biology for
CD276 Recombinant Protein (OPCD01998)

Request Info

Description

Modulates T-cell-mediated immune responses and the development of acute and chronic transplant rejection. Plays a positive regulatory role in bone formation and has a dual role in the bone-immune interface. Induces antitumor immunity as it activates both acquired and innate immunity leading to natural killer cell and CD8 T-cell dependent killing of tumor cells